|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,239.00 JPY | +0.40% |
|
-0.49% | +9.86% |
| 06-25 | Declaration of Voting Results by Asuka Pharmaceutical | CI |
| 05-27 | Dalton Investment strongly oppose conditional activation of countermeasures announced by ASKA Pharmaceutical Holdings on May 25 | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 2,417 | 2,995 | 2,992 |
| Spread/Res. | -7.36% | -25.24% | -25.17% |
| Spread/Supp. | +2.94% | +6.32% | +16.07% |
| Support | 2,175 | 2,106 | 1,929 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4886 Stock
- Charts ASKA Pharmaceutical Holdings Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
